Renaissance Capital logo

SELB News

Nanoparticle biotech Selecta Biosciences prices upsized IPO at $14, the low end of the range

Selecta Biosciences logo

Selecta Biosciences, which is developing nanoparticles that modulate the immune system to enhance biologics, raised $70 million by offering 5 million shares at $14. It had originally planned to raise $64 million by offering 4.25 million shares at $14 to $16....read more

US IPO Week Ahead: IPO market discovers whether unicorns can fly with tech firm Twilio

TWLO

All eyes are on communications tech IPO Twilio (TWLO). The reception of its offering will send a message to other tech unicorns that have been called out for...read more

Are nanoparticles the next big thing? Selecta Biosciences sets terms for $64 million IPO

Selecta Biosciences logo

Selecta Biosciences, which is developing nanoparticles that modulate the immune system to enhance drugs, announced terms for its IPO on Wednesday. The Watertown, MA-based company plans to raise $64 million by offering 4.3 million shares at a price range of...read more

Think nano: Selecta Biosciences files for a $75 million IPO to fund nanoparticle immunotherapies

Selecta Biosciences logo

Selecta Biosciences, which is developing immunotherapies based on its proprietary nanoparticle platform, filed on Tuesday with the SEC to raise up to $75 million in an initial public offering. The Watertown, MA-based company was founded in 2007 and plans to...read more

Archived Headlines